Asian American
Asian American and Pacific Islander (AAPI) Health Disparities (2022–2023 Aligned)
Overview
Asian American and Pacific Islander populations represent a highly diverse group with wide variation in health outcomes. Modern CDC-era data (2022–2023) continues to show that disaggregated subgroups experience significant disparities in infectious disease, cancer burden, and preventive care access.
Access to Healthcare (Current Trends)
Approximately 2022–2023 national analyses continue to show:
- Higher uninsured rates in certain AAPI subgroups compared to white populations
- Language and cultural barriers impacting preventive care utilization
- Under-screening in multiple chronic disease categories
Infectious Disease Burden
Tuberculosis (TB)
AAPI populations continue to experience the highest TB burden in the United States, despite overall national declines.
Hepatitis B (HBV)
Chronic hepatitis B remains disproportionately concentrated in AAPI communities and is a major contributor to elevated liver cancer risk.
Cancer Disparities (Persistent Patterns)
Certain AAPI subgroups continue to show elevated cancer risk:
- Liver cancer remains disproportionately high in populations with higher HBV prevalence
- Cervical cancer disparities persist in subgroups with lower screening access
Historical Baseline (Context)
Earlier surveillance (1988–2001) showed:
- Extremely elevated liver cancer rates in Vietnamese American men
- High cervical cancer incidence in Vietnamese American women
- TB rates significantly higher than all other racial/ethnic groups at the time
National Institute on Minority Health and Health Disparities
Asian American children at higher risk for allergies
Why are Asian Americans at higher risk for diabetes?
Why thousands of elderly Asian Americans skip basic healthcare